392 related articles for article (PubMed ID: 14769533)
21. Molecular targets for green tea in prostate cancer prevention.
Adhami VM; Ahmad N; Mukhtar H
J Nutr; 2003 Jul; 133(7 Suppl):2417S-2424S. PubMed ID: 12840218
[TBL] [Abstract][Full Text] [Related]
22. The role of prostate-specific antigen in the chemoprevention of prostate cancer.
Crawford ED; DeAntoni EP; Ross CA
J Cell Biochem Suppl; 1996; 25():149-55. PubMed ID: 9027612
[TBL] [Abstract][Full Text] [Related]
23. Prevention of hormone-related cancers: prostate cancer.
Parnes HL; Thompson IM; Ford LG
J Clin Oncol; 2005 Jan; 23(2):368-77. PubMed ID: 15637399
[TBL] [Abstract][Full Text] [Related]
24. Epigallocatechin-3-Gallate suppresses early stage, but not late stage prostate cancer in TRAMP mice: mechanisms of action.
Harper CE; Patel BB; Wang J; Eltoum IA; Lamartiniere CA
Prostate; 2007 Oct; 67(14):1576-89. PubMed ID: 17705241
[TBL] [Abstract][Full Text] [Related]
25. Chemopreventive effects of tea extracts and various components on human pancreatic and prostate tumor cells in vitro.
Lyn-Cook BD; Rogers T; Yan Y; Blann EB; Kadlubar FF; Hammons GJ
Nutr Cancer; 1999; 35(1):80-6. PubMed ID: 10624710
[TBL] [Abstract][Full Text] [Related]
26. Green tea polyphenols for prostate cancer chemoprevention: a translational perspective.
Johnson JJ; Bailey HH; Mukhtar H
Phytomedicine; 2010 Jan; 17(1):3-13. PubMed ID: 19959000
[TBL] [Abstract][Full Text] [Related]
27. Effect of a prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate on the growth of androgen-independent prostate cancer in vivo.
Lee SC; Chan WK; Lee TW; Lam WH; Wang X; Chan TH; Wong YC
Nutr Cancer; 2008; 60(4):483-91. PubMed ID: 18584482
[TBL] [Abstract][Full Text] [Related]
28. Molecular targets for the cancer preventive activity of tea polyphenols.
Yang CS; Lambert JD; Hou Z; Ju J; Lu G; Hao X
Mol Carcinog; 2006 Jun; 45(6):431-5. PubMed ID: 16652355
[TBL] [Abstract][Full Text] [Related]
29. Green tea polyphenols and metabolites in prostatectomy tissue: implications for cancer prevention.
Wang P; Aronson WJ; Huang M; Zhang Y; Lee RP; Heber D; Henning SM
Cancer Prev Res (Phila); 2010 Aug; 3(8):985-93. PubMed ID: 20628004
[TBL] [Abstract][Full Text] [Related]
30. Catechin and caffeine content of green tea dietary supplements and correlation with antioxidant capacity.
Seeram NP; Henning SM; Niu Y; Lee R; Scheuller HS; Heber D
J Agric Food Chem; 2006 Mar; 54(5):1599-603. PubMed ID: 16506807
[TBL] [Abstract][Full Text] [Related]
31. An update on chemoprevention strategies in prostate cancer for 2006.
Neill MG; Fleshner NE
Curr Opin Urol; 2006 May; 16(3):132-7. PubMed ID: 16679848
[TBL] [Abstract][Full Text] [Related]
32. Significance of chemoprevention for prostate cancer development: experimental in vivo approaches to chemoprevention.
Shirai T
Pathol Int; 2008 Jan; 58(1):1-16. PubMed ID: 18067635
[TBL] [Abstract][Full Text] [Related]
33. Prostate cancer chemoprevention: current status and future prospects.
Gupta S
Toxicol Appl Pharmacol; 2007 Nov; 224(3):369-76. PubMed ID: 17189645
[TBL] [Abstract][Full Text] [Related]
34. A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma.
Jatoi A; Ellison N; Burch PA; Sloan JA; Dakhil SR; Novotny P; Tan W; Fitch TR; Rowland KM; Young CY; Flynn PJ
Cancer; 2003 Mar; 97(6):1442-6. PubMed ID: 12627508
[TBL] [Abstract][Full Text] [Related]
35. Prooxidant property of green tea polyphenols epicatechin and epigallocatechin-3-gallate: implications for anticancer properties.
Azam S; Hadi N; Khan NU; Hadi SM
Toxicol In Vitro; 2004 Oct; 18(5):555-61. PubMed ID: 15251172
[TBL] [Abstract][Full Text] [Related]
36. Tea polyphenols down-regulate the expression of the androgen receptor in LNCaP prostate cancer cells.
Ren F; Zhang S; Mitchell SH; Butler R; Young CY
Oncogene; 2000 Apr; 19(15):1924-32. PubMed ID: 10773882
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms of hypolipidemic and anti-obesity effects of tea and tea polyphenols.
Lin JK; Lin-Shiau SY
Mol Nutr Food Res; 2006 Feb; 50(2):211-7. PubMed ID: 16404708
[TBL] [Abstract][Full Text] [Related]
38. Tea polyphenols decrease serum levels of prostate-specific antigen, hepatocyte growth factor, and vascular endothelial growth factor in prostate cancer patients and inhibit production of hepatocyte growth factor and vascular endothelial growth factor in vitro.
McLarty J; Bigelow RL; Smith M; Elmajian D; Ankem M; Cardelli JA
Cancer Prev Res (Phila); 2009 Jul; 2(7):673-82. PubMed ID: 19542190
[TBL] [Abstract][Full Text] [Related]
39. Advances in prostate cancer chemoprevention: a translational perspective.
Nambiar D; Singh RP
Nutr Cancer; 2013; 65 Suppl 1():12-25. PubMed ID: 23682779
[TBL] [Abstract][Full Text] [Related]
40. White and green teas (Camellia sinensis var. sinensis): variation in phenolic, methylxanthine, and antioxidant profiles.
Unachukwu UJ; Ahmed S; Kavalier A; Lyles JT; Kennelly EJ
J Food Sci; 2010 Aug; 75(6):C541-8. PubMed ID: 20722909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
